SLPI Produkte
(Secretory Leukocyte Peptidase Inhibitor (SLPI))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte SLPI Kategorien
SLPI Antikörper
High quality antibodies with extensive validation data.
SLPI ELISA Kits
Reliable ELISA kits for a wide range of species.
SLPI Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene SLPI Antikörper
- (5)
- (3)
- (3)
Empfohlene SLPI ELISA Kits
- (1)
- (1)
- (1)
- (1)
- (1)
Empfohlene SLPI Proteine
- (3)
- (2)
- (1)
- (1)
Neueste Publikationen zu unseren SLPI Produkten
: "Editor's Highlight: Candidate Risk Factors and Mechanisms for Tolvaptan-Induced Liver Injury Are Identified Using a Collaborative Cross Approach." in: Toxicological sciences : an official journal of the Society of Toxicology, Vol. 156, Issue 2, pp. 438-454, (2018) (PubMed).: "Serum alarm antiproteases in systemic sclerosis patients." in: Human immunology, Vol. 78, Issue 9, pp. 559-564, (2018) (PubMed).
: "Secretory leukocyte protease inhibitor regulates human periodontal ligament cell production of pro-inflammatory cytokines." in: Inflammation research : official journal of the European Histamine Research Society ... [et al.], Vol. 66, Issue 9, pp. 823-831, (2018) (PubMed).
: "Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells." in: PLoS ONE, Vol. 9, Issue 8, pp. e104223, (2015) (PubMed).
: "Activated microglia enhance neurogenesis via trypsinogen secretion." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Issue 21, pp. 8714-9, (2013) (PubMed).
: "Secretory leukocyte protease inhibitor inhibits neutrophil apoptosis." in: Respirology (Carlton, Vic.), Vol. 16, Issue 2, pp. 300-7, (2011) (PubMed).
: "Overexpression of a secretory leukocyte protease inhibitor in human gastric cancer." in: International journal of cancer. Journal international du cancer, Vol. 123, Issue 8, pp. 1787-96, (2008) (PubMed).
: "WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung." in: Respiratory research, Vol. 7, pp. 61, (2006) (PubMed).
: "Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity." in: Journal of virology, Vol. 79, Issue 10, pp. 6432-40, (2005) (PubMed).
: "Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding." in: The Journal of experimental medicine, Vol. 202, Issue 12, pp. 1659-68, (2005) (PubMed).
Synonyme und alternative Namen zu SLPI
secretory leukocyte peptidase inhibitor (SLPI), secretory leukocyte peptidase inhibitor (Slpi), antileukoproteinase (LOC102174044), ALK1, ALP, BLPI, ckpi, HUSI, HUSI-I, MATN4, MPI, SLPI, WAP4, WFDC4Bezeichner auf Proteinebene für SLPI
- HUSI-1
- WAP four-disulfide core domain protein 4
- antileukoproteinase
- mucus proteinase inhibitor
- protease inhibitor WAP4
- secretory leukocyte protease inhibitor (antileukoproteinase)
- seminal proteinase inhibitor
- ALP
- secretory leukocyte protease inhibitor
- matrilin 4
- secretory leukocyte peptidase inhibitor